Trials / Terminated
TerminatedNCT02982200
Medina Embolization Device In Neurovascular Aneurysm Study
The MEDINA Study: Medina Embolization Device In Neurovascular Aneurysms Study - A Post Market Clinical Follow-up Study
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Medtronic Neurovascular Clinical Affairs · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
A global prospective, multi-center, single-arm, post-market clinical follow-up (PMCF) study conducted to assess the performance of the Medina Embolization Device when used in unruptured and ruptured intracranial aneurysms.
Conditions
Timeline
- Start date
- 2016-12-15
- Primary completion
- 2018-10-22
- Completion
- 2018-10-22
- First posted
- 2016-12-05
- Last updated
- 2019-05-17
Locations
3 sites across 3 countries: Austria, Italy, Spain
Source: ClinicalTrials.gov record NCT02982200. Inclusion in this directory is not an endorsement.